期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
18F-fluorodeoxyglucose Uptake with Expression of Excision Repair Cross-complementary Group I and Ribonucleotide Reductase Subunit M1 in Non-small Cell Lung Cancer
1
作者 Na Hu Yun-Hua Wang +2 位作者 Dai-Qiang Li Xiao-Huang Yang Yan-Lin Tan 《Chinese Medical Journal》 SCIE CAS CSCD 2017年第17期2117-2118,共2页
Fluorodeoxyglucose positron emission tomography/conlputed tomography (FDG PET/CT) is widely applied in non-small cell lung cancer (NSCLC). The standardized uptake value (SUV), a semi-quantitative index, plays an... Fluorodeoxyglucose positron emission tomography/conlputed tomography (FDG PET/CT) is widely applied in non-small cell lung cancer (NSCLC). The standardized uptake value (SUV), a semi-quantitative index, plays an essential role in NSCLC tbr diagnosis, staging, and efficacy evaklation. It has been px3posed that the SUV of tumors may correlate with the presence or absence of chemotherapy resistance-associated biomarkers based on studies that have displayed a close correlation between SUV and the expression levels of excision repair cross-complementary Group 1 (ERCC 1 )1~1 and Tp53-induced glycolysis and apoptosis regulator.121 FDG avidity of NSCLC and ERCC 1 and ribonucleotide reductase subunit M 1 (RRM 1 ) levels have not been as extensively investigated. Based on these findings, we looked tbr correlations among metabolic parameters (SUVm,,. metabolic tumor volume [MTV], and total lesion glycolysis [TLG]) and ERCC1 and RRM1 expression in patients with NSCLC, to investigate whether FDG uptake reflects the presence or absence ofchemoresistance proteins (ERCC1 and RRM 1 ) within tumor cells. 展开更多
关键词 Computed Tomography: excision Repair Cross-complementary Group 1: Non-small Cell lung Cancer: Positron-emission Tomography Ribonucleotide Reductase Subunit M 1
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部